Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Weatherhead School’s J.B. Silvers answers questions about impact of Obamacare on amount of uninsured Americans
- Psychology’s Lisa Damour writes about false perception that girls are meaner than their male peers
- History professor’s Twitter account goes viral—again
- Give to “Shop with a Cop” fundraiser to help local families
- Learn how to help students navigate study abroad process at Dec. 3 Global Talk session